1stabirateroneacademicacceleratedadcsadjuvantadvancedandreaantiantibodyapcccapproachesapprovalascoasco24atezolizumabauabasedbcgbelzutifanbiomarkerbiomarkersbispecificbladderbonecabozantinibcanariascanarycancercancerscarcinomacareercellcheckmatechemochinachoueirichristmasclassificationclearclinicalcombinationsconferenceconsensuscontact2cosmiccovidcrpcctdnacupcystectomydatadebatedevelopmentdiagnosticsdirecteddiscussesdiscussingdiscussiondiseasedoubletsdrdrugdrugsearlyeauefficacyeikcsenzaenzalutamideerdafitinibesmofdafgfrfinalfirstfrontfuturegalskygermgermanygoodguguidelineshifhighhighlightsholidayhormoneiiiimmuneimmunityinhibitioninhibitorioipiipilimumabislandsjapankeynotekidneykimlegendslinelivelulungmaintenancemattmcrpcmdmeetmeetingmeetingsmetastaticmolecularmonotherapymonthnashvilleneoadjuvantniagaranicknivonivolumabnmibcnovelodacolapariboncologyoverviewpaperpapillarypatientspdpd1pembropembrolizumabperspectivepetphasepostpreviewprostataprostateprostatectomypsmaqolradiotherapyrccrefractoryrenalresistanceresultsresumenreunionreviewrisingriskrolescoreseriessessionsparingspecialstampedestarstudiesstudysummarysunrisesurgerysurveillancesurvivalsymposiumtalaprotalazoparibtargetingtherapytomtonitoripalimabtourtreatmenttrestrialtrialstriplettropicsucunresponsiveupdateupdatedupdatesuromigosliveuromigoslive24urothelialvedotinvegfworldyear